Abstract
A multi-scale parameterization approach, factor analysis scales of generalized amino acid information combined with auto cross covariance, was used to develop quantitative sequence-activity models of peptides using support vector machines. The results demonstrated that this approach could well characterize sequence features of the peptides studied.
Keywords: Factor analysis scales of generalized amino acid information (FASGAI), auto cross covariance (ACC), FASGAI-ACC, quantitative sequence-activity model (QSAM), support vector machines (SVM)
Protein & Peptide Letters
Title: A Multi-Scale Parameterization Approach of Peptides for Quantitative Sequence-Activity Models
Volume: 17 Issue: 5
Author(s): Weihuan Niu, Qingyou Xia and Guizhao Liang
Affiliation:
Keywords: Factor analysis scales of generalized amino acid information (FASGAI), auto cross covariance (ACC), FASGAI-ACC, quantitative sequence-activity model (QSAM), support vector machines (SVM)
Abstract: A multi-scale parameterization approach, factor analysis scales of generalized amino acid information combined with auto cross covariance, was used to develop quantitative sequence-activity models of peptides using support vector machines. The results demonstrated that this approach could well characterize sequence features of the peptides studied.
Export Options
About this article
Cite this article as:
Niu Weihuan, Xia Qingyou and Liang Guizhao, A Multi-Scale Parameterization Approach of Peptides for Quantitative Sequence-Activity Models, Protein & Peptide Letters 2010; 17 (5) . https://dx.doi.org/10.2174/092986610791112738
DOI https://dx.doi.org/10.2174/092986610791112738 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
COVID-19: Challenges and its Technological Solutions using IoT
Current Medical Imaging A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2
Coronaviruses Novel Coronavirus Disease and the Current Scenario of the Global Health Emergency
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies
Current Molecular Pharmacology The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19
Current Stem Cell Research & Therapy The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study
Endocrine, Metabolic & Immune Disorders - Drug Targets A Viewpoint on Potential Biomarkers for Infectious COVID-19 Severity: An Updated Literature Survey
Infectious Disorders - Drug Targets Comparison of Clinical Characteristics, Laboratory Findings and Imaging Manifestations of COVID-19 in Sulfur Mustard-exposed Survivors and Others: a Case-control Study
Current Drug Therapy The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-Review
Current Pharmaceutical Biotechnology Treatment of Disorders Characterized by Reversible Airway Obstruction in Childhood: are Anti-cholinergic Agents the Answer?
Current Pharmaceutical Design Withdrawal Notice: The Relationship between Opium Use and Coronavirus Infection: A Brief Research Report from Iran
Coronaviruses Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach
Current Pharmaceutical Design Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
Current Medicinal Chemistry Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method
Current Pharmaceutical Analysis Novel Coronavirus (COVID-19) Outbreak: Hope and Search for Effective Therapeutic Agent
Letters in Drug Design & Discovery Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials
Coronaviruses Therapeutic Agents Against COVID-19 with Clinical Evidence
Current Pharmaceutical Design Can Nutrition Play a Role as a Stimulant for COVID 19 in Children?
Reviews on Recent Clinical Trials Does Hypofractionated Radiotherapy Regimens Increase the Vulnerability to SARS- COV-2 by Influencing ACE-2 Activity?
Coronaviruses Respiratory Therapeutic Strategies in Children and Adolescents with COVID-19: A Critical Review
Current Pediatric Reviews